United States - English - NLM (National Library of Medicine)

strategic sourcing services llc - dimenhydrinate (unii: jb937per5c) (diphenhydramine - unii:8gts82s83m, 8-chlorotheophylline - unii:ge2ua340fm) - antiemetic for prevention and treatment of these symptoms associated with motion sickness: - nausea - vomiting - dizziness

United States - English - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - clonazepam (unii: 5pe9fde8gb) (clonazepam - unii:5pe9fde8gb) - clonazepam 0.5 mg - seizure disorders: clonazepam tablets, usp are useful alone or as an adjunct in the treatment of the lennox-gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. in patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam may be useful. in some studies, up to 30% of patients have shown a loss of anticonvulsant activity, often within 3 months of administration. in some cases, dosage adjustment may reestablish efficacy. panic disorder: clonazepam tablets, usp are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in dsm-iv. panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks. the efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the dsm-iiir

United States - English - NLM (National Library of Medicine)

puracap pharmaceutical llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 25 mg - antiemetic for prevention and treatment of these symptoms associated with motion sickness: - nausea - vomiting - dizziness

United States - English - NLM (National Library of Medicine)

chain drug consortium, llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - meclizine hydrochloride 25 mg - antiemetic for the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness

United States - English - NLM (National Library of Medicine)

quality care products, llc - clonazepam (unii: 5pe9fde8gb) (clonazepam - unii:5pe9fde8gb) - seizure disorders clonazepam tablets, usp are useful alone or as an adjunct in the treatment of the lennox-gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. in patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam may be useful. some loss of effect may occur during the course of clonazepam treatment (see precautions, loss of effect ). panic disorder clonazepam tablets, usp are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in dsm-v. panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks. the efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the dsm-iiir category of panic disorder (see clinical pharmacology, clinical trials

United States - English - NLM (National Library of Medicine)

pharmacy value alliance, llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic for the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness

United States - English - NLM (National Library of Medicine)

pharmacy value alliance, llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic for the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 500 mg - carefully consider the potential benefits and risks of naproxen delayed-release tablets and other treatment options before deciding to use naproxen delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naproxen delayed-release tablets are indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. naproxen delayed-release tablets are not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products (see clinical pharmacology and dosage and administratio

United States - English - NLM (National Library of Medicine)

motion medicine inc. - camphor (synthetic) (unii: 5tjd82a1et) (camphor (synthetic) - unii:5tjd82a1et), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - camphor (synthetic) 4 g in 100 g - for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains, etc. pain reliever

United States - English - NLM (National Library of Medicine)

washington homeopathic products - cocculus    6c, nux vom   6c, petroleum       6c - to relieve the symptoms of traveling sickness from any cause.  characterized by dizziness, intense nausea, vomiting. indications: cocculus    motion sickness nux vom   vomiting petroleum     nausea if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.